Connect with us

Technology

Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA

Published

on

HONG KONG, June 30, 2024 /PRNewswire/ — Yidu Tech Inc. (“Yidu Tech” or the “Company”, together with its subsidiaries and consolidated affiliated entities, the “Group”, HKEX: 2158) announced its annual results for the fiscal year ended 31 March 2024 (“FY2024” or the “Reporting Period”). The management provided detailed explanations on the key performance highlights, development strategies, and future outlook. Owing to the Company’s “Focus” strategy, Yidu Tech has seen further improvements in operational efficiency, profitability, and business competitiveness.

The Company’s total revenue in FY2024 was recorded at RMB 807.1 million, and gross profit margin increased to 42.1% from 34.1% year-on-year (“YoY”), representing an increase of 8.0 percentage points, hitting an all-time high. Adjusted net loss narrowed from RMB448.7 million to RMB158.1 million, down 64.8% YoY, and cash flow continued to be optimized. During the reporting period, the Company continued to invest in AI technology, especially in the development and commercialization of its proprietary large language model in the medical vertical field to maintain a leading position in the opportunities of the large language model era.

During the results conference, Yidu Tech’s management stated that excluding strategic investments in proprietary large language model, non-cash items, and non-operating items, the adjusted EBITDA for our current business has achieved profitability, moving from a RMB 327 million loss to a profit of RMB 31.1 million for the first time this fiscal year. “It further elaborated that this could be largely attributed to the effects of the Company’s timely adoption of the ‘Focus’ strategy. In the face of new opportunities for technological innovation and industrial upgrading driven by generative AI technology, the Company seeks to further play a leading role in innovation, accelerate the commercialization of large language models in healthcare, and provide safer, more inclusive, and more precise intelligent solutions for the entire medical ecosystem, in order to create long-lasting value for investors.”

Yidu Tech’s management commented during the results conference that the Company’s operating cash outflow continues to improve, and that it is no longer spending extensively on its operations. Over the past three fiscal years, the Company’s net operating cash outflow has decreased consecutively each year. In FY2022, the figure was recorded at RMB 639 million, in FY2023, it decreased to RMB 463 million, and in FY2024, it further dropped to RMB 230 million. If this trend continues, cash flow is expected to break even in the new fiscal year. 

Management added that as of market close on June 27, the Company’s P/B ratio has decreased to 1.06. Not including the valuation of its domestic and international businesses, its market value is still lower than its fund reserves on hand. As such, management believes that the Company’s share price is still severely undervalued. Notably, renowned sovereign fund BIA has continually increased its shareholding of Yidu Tech by 21.50% over the past two months. The management is confident in the Company’s long-term growth potential and hopes to continually create innovative technologies and increase returns to its shareholders.

Continuous Upgrade of the “AI Medical Brain”, Breakthroughs in “Technology + Application”

Over the past year, the Company has continued to upgrade and iterate YiduCore, its “AI Medical Brain”, comprehensively strengthening its functions in processing efficiency, comprehension and reasoning capabilities, as well as precise adaptation to complex application scenarios. During the reporting period, the Company has continued the development and training of large language model in the medical vertical field based on 500 billion fine-trained Tokens, with model training for 6B, 13B, and 70B parameters completed. Yidu Tech’s proprietary large language model has passed the deep synthesis service algorithm filings of Cyberspace Administration of China.

In terms of data, YiduCore has cumulatively processed and analyzed more than 5 billion authorized medical records from over 1 billion patients, covering over 2,500 hospitals.

In terms of algorithms, in May 2024, in the MedBench evaluation, an authoritative evaluation platform launched by Shanghai AI Laboratory and Shanghai Digital Medicine Innovation Center, Yidu Tech’s large language model ranked first in each of the three key dimensions of medical knowledge Q&A, medical language understanding, and medical safety and ethics, and achieved the highest overall score.

In addition to technological breakthroughs, YiduCore’s commercial applications have also continuously expanding. By leveraging Yidu Tech’s large language model, the Company has enhanced project sustainability and provided 24/7 health management services to over 5 million users.

Large Language Model Empowering a Comprehensive Healthcare Ecosystem Solution, Three Major Segments Progressing in Synergy

Driven by the core technologies of YiduCore, the Company’s three major business segments are progressing in synergy, further solidifying its prominent market position.

During the reporting period, the revenue of the Company’s Big Data Platform and Solutions segment reached RMB 313.6 million, representing a YoY increase of 41.4%. As of 31 March 2024, the total number of the Company’s top hospital clients increased by 14 to 102 as compared to the same period last year, while the number of regulator and policymaker clients increased by 9 to 43.

Revenue from the Company’s Life Sciences Solutions segment amounted to RMB 324.0 million, representing a YoY increase of 28.1%, with gross margin increasing by 14.6 percentage points to a historical high of 32.1%. As of 31 March 2024, the Company achieved a 151.1% revenue retention rate for its top 10 clients in terms of revenue, with average transaction value of customers increasing by 75.4% YoY. Among 20 of the top multinational pharmaceutical companies (MNCs), 16 of them constitute the Company’s clients. In terms of clinical research, the Company has performed 321 clinical research cases, including clinical trials sponsored by pharmaceutical companies and investigator-initiated trials, as well as 246 prospective and retrospective real world studies (RWS).

Finally, revenue from the Health Management Platform and Solutions segment was recorded at RMB 169.5 million, with gross profit margin hitting 58.1%, up 17.4 percentage points YoY. During the reporting period, the Company continued to increase its market penetration rate of the government’s supplemental Medicare program, Hui Min Bao (惠民保), as well as cumulatively winning bids and serving 4 provinces and 12 cities, including Jiangsu Province, Beijing, Shenzhen etc. As of 31 March 2024, the number of active users who have completed at least one transaction on Yidu Tech’s health management platform increased to nearly 27.6 million.

The arrival of the large language model era has accelerated the popularization and penetration of artificial intelligence in the healthcare industry. As a leading company in China’s AI medical industry, Yidu Tech strives to seize any relevant market opportunities created by generative AI and large language models by firmly investing and innovating in this domain. At the same time, the Company will also continue to consolidate its business model, improve operational efficiency, and achieve sustainable improvements in profitability and growth, in order to generate increasing long-term, high-quality value to stakeholders in the healthcare ecosystem.

View original content:https://www.prnewswire.com/news-releases/yidu-tech-announces-annual-results-for-fy-2024-existing-business-achieves-first-full-year-profit-on-adjusted-ebitda-302185832.html

SOURCE Yidu Tech

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Movano Health’s Board of Directors Initiates Process to Maximize Shareholder Value

Published

on

By

PLEASANTON, Calif., May 16, 2025 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in health technology, announced today that its Board of Directors has initiated a process to explore strategic alternatives, including a sale, merger or similar transaction involving the Company, to maximize shareholder value.  To support this process, Movano Health’s Board of Directors has engaged Aquilo Partners as its financial advisor and K&L Gates LLP as its legal counsel.

There can be no assurance that this process will result in any transaction or other strategic change or as to the timing of any such potential agreement or transaction. Movano Health does not intend to disclose further developments unless and until the Board of Directors has approved a specific course of action or determines that further disclosure is appropriate or required.  The Company also reported that due to resource constraints, it does not plan to timely file its quarterly report on Form 10-Q for the quarter ended March 31, 2025.

About Movano Health 
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health is developing a suite of purpose-driven healthcare solutions to bring medical-grade data to the forefront of wearables. Featuring modern and flexible form factors, Movano Health’s devices offer an innovative approach to delivering trusted data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and uniquely translating it into personalized and intelligent insights.

Movano Health’s proprietary technologies and wearable medical device solutions enable the use of data as a tool to proactively monitor and manage health outcomes across a number of patient populations that exist in healthcare. For more information on Movano Health, visit https://movanohealth.com/.

Forward Looking Statements

This press release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially from those anticipated. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding the Company’s strategic plans and value, plans with respect to the commercial launches of the Evie Ring and EvieMED; our expectations regarding potential commercial opportunities and addressable markets; planned cost-cutting initiatives; anticipated FDA clearance decisions with respect to our products; expected future operating results; product development efforts and product releases; clinical trial and regulatory initiatives; commercial partner activities; our strategies, positioning and expectations for future events or performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption “Risk Factors.”  Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

View original content to download multimedia:https://www.prnewswire.com/news-releases/movano-healths-board-of-directors-initiates-process-to-maximize-shareholder-value-302458030.html

SOURCE Movano

Continue Reading

Technology

Canaan Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements

Published

on

By

SINGAPORE, May 16, 2025 /PRNewswire/ — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), an innovator in crypto mining, today announced that on May 13, 2025, it received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the closing bid price of its American depositary shares (the “ADSs”) was below US$1.00 per share for the last 30 consecutive business days. The Nasdaq notification letter has no immediate effect on the listing or trading of the Company’s securities on Nasdaq.

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar-day compliance period, or until November 10, 2025, to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s ADSs must meet or exceed US$1.00 per share for at least 10 consecutive business days during the 180-calendar-day compliance period.

In the event the Company does not regain compliance by November 10, 2025, subject to the determination by the staff of Nasdaq, the Company may be eligible for an additional 180-calendar-day compliance period. To qualify for this additional time, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market with the exception of the minimum bid price requirement and will need to provide written notice of its intention to cure the deficiency during the second compliance period. If the Company does not regain compliance within the allotted compliance period(s), including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s ADSs will be subject to delisting.

The Company intends to continue monitoring the closing bid price of its ADSs and will take all reasonable measures in order to regain compliance with the Nasdaq minimum bid price requirement. The Company’s ADSs will continue to be listed and trade on the Nasdaq Global Market during the compliance period, unaffected by the receipt of the Notice from Nasdaq.

This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.

About Canaan Inc.

Established in 2013, Canaan Inc. (NASDAQ: CAN), is a technology company focusing on ASIC high-performance computing chip design, chip research and development, computing equipment production, and software services. Canaan has extensive experience in chip design and streamlined production in the ASIC field. In 2013, Canaan’s founding team shipped to its customers the world’s first batch of mining machines incorporating ASIC technology in bitcoin‘s history under the brand name Avalon. In 2019, Canaan completed its initial public offering on the Nasdaq Global Market. To learn more about Canaan, please visit https://www.canaan.io/.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates” and similar statements. Among other things, the business outlook and quotations from management in this announcement, as well as Canaan Inc.’s strategic and operational plans, contain forward-looking statements. Canaan Inc. may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (“SEC”) on Forms 20-F and 6-K, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Canaan Inc.’s beliefs and expectations, such as expectations with regard to mining hash rate deployment, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s goals and strategies; the Company’s future business development, the ability of the company to execute against its goals, financial condition and results of operations; the expected growth of the bitcoin industry and the price of bitcoin; the Company’s expectations regarding demand for and market acceptance of its products, especially its bitcoin mining machines; the Company’s expectations regarding maintaining and strengthening its relationships with production partners and customers; the Company’s investment plans and strategies, fluctuations in the Company’s quarterly operating results; competition in its industry; changing macroeconomic and geopolitical conditions, including evolving international trade policies and the implementation of increased tariffs, import restrictions, and retaliatory trade actions; and relevant government policies and regulations relating to the Company and cryptocurrency. Further information regarding these and other risks is included in the Company’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Canaan Inc. does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact

Canaan Inc.
Xi Zhang
Email: IR@canaan-creative.com

ICR, LLC.
Robin Yang
Tel: +1 (347) 396-3281
Email: canaan.ir@icrinc.com

View original content:https://www.prnewswire.com/news-releases/canaan-inc-receives-nasdaq-notification-regarding-minimum-bid-requirements-302458116.html

SOURCE Canaan Inc.

Continue Reading

Technology

BOARDWALKTECH ANNOUNCES NEW NON-BROKERED LIFE OFFERING AND CLOSES PRIOR OFFERING

Published

on

By

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

CUPERTINO, Calif., May 16, 2025 /CNW/ – (TSXV: BWLK) (OTCQB: BWLKF) Boardwalktech Software Corp. (the “Company” or “Boardwalktech”) announces, subject to the approval of the TSX Venture Exchange (the “TSXV”), that it intends to complete a new non-brokered private placement for gross proceeds of up to C$750,000 (the “Offering”) pursuant to the Listed Issuer Financing Exemption (the “LIFE”) of National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”) in conjuncture with the Closing of its prior offering announced on February 26, 2025 (“Prior Offering”).

The new Offering will consist of up to 5,769,231 units of the Company (each, a “Unit”, and collectively the “Units”) at a price of C$0.13 per Unit. Each Unit will be comprised of one Common Share (each, a “Common Share”, and collectively the “Common Shares”) and one Common Share purchase warrant (each whole warrant, a “Warrant” and collectively the “Warrants”). Each Warrant will entitle the holder thereof to acquire one Common Share at a price of C$0.25 per Common Share for a period of 12 months from the closing date of the Offering.

Subject to compliance with applicable regulatory requirements, and in accordance with NI 45-106, the Offering is being made to purchasers resident in Canada pursuant to the LIFE Part 5A of NI 45-106. The securities issued under the Offering will not be subject to a hold period in accordance with applicable Canadian securities laws.

There is an offering document related to the Offering that can be accessed under the Company’s profile at www.sedarplus.com and on the Company’s website at https://ir.boardwalktech.com/form-page. Prospective investors should read this offering document before making an investment decision.

The Company expects to use the net proceeds of the Offering for sales and marketing expenditures, working capital requirements, and to enhance its balance sheet to drive new business. Closing of the Offering is expected to occur on or about May 29, 2025, or such other date as the Company may decide, and remains subject to the Company obtaining all necessary corporate and regulatory approvals, including approval of the TSXV. The Company may pay finders’ fees in connection with the Offering and in accordance with the policies of the TSXV.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release. Such securities have not been, and will not be, registered under the U.S. Securities Act, or any state securities laws, and, accordingly, may not be offered or sold within the United States, or to or for the account or benefit of persons in the United States or “U.S. Persons”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.

Close of Prior Offering

As previously announced on March 17, 2025, the Company has closed, subject to the final approval of the TSXV, its Prior Offering consisting of 8,576,573 Units at the price of C$0.13 per Unit pursuant to the LIFE, which was previously announced on February 27, 2025. In the Prior Offering, the Company also issued an additional 250,000 Units to United States investors pursuant to other applicable prospectus exemptions, at US$0.09 (equivalent of C$0.13) with equivalent commercial terms for each Warrant per Unit. The securities issued to United States investors remain subject to a hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation. Collectively across the Prior Offering a total of 8,826,573 Units were issued, resulting in aggregate gross proceeds of approximately C$1,147,454.

In connection with the close of the Prior Offering, the Company paid aggregate finder fees of approximately C$40,169 in cash commissions and 308,996 non-transferrable Warrants of the Company exercisable until March 14, 2026 to acquire one Common Share at an exercise price of C$0.25 (the “Finder’s Warrants”). The Finder’s Warrants are subject to a hold period of four months plus one day from the date of issuance in accordance with applicable securities legislation.

Certain insiders of the Company subscribed for an aggregate of 250,000 Units in the Prior Offering and, as such, the Prior Offering may constitute a related party transaction under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”), but is otherwise exempt from the formal valuation and minority approval requirements of MI 61-101 by virtue Sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of such insider participation.

On Behalf of the Company

Andrew Duncan,
CEO & Chairman

About Boardwalktech Software Corp.

Boardwalktech has developed a patented Digital Ledger Technology Platform currently used by Fortune 500 companies running mission-critical applications worldwide. Boardwalktech’s digital ledger technology and its unique method of managing vast amounts of structured and unstructured data is the only platform on the market today where multiple parties can effectively work on the same data simultaneously while preserving the fidelity and provenance of the data. Boardwalktech can deliver collaborative, purpose-built enterprise information management applications on any device or user interface with full integration with enterprise systems of record in a fraction of the time it takes other non-digital ledger technology-based platforms. Boardwalktech is headquartered in Cupertino, California with offices in India and operations in North America. For more information on Boardwalktech, visit our website at www.boardwalktech.com.

Legal Disclaimer

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information, visit www.boardwalktech.com or contact:

Charlie Glavin, CFA
Boardwalktech, Inc.
charlie.glavin@boardwalktech.com  
650-618-6163

Sean Peasgood
Investor Relations
sean@sophiccapital.com
647.837.3357

Forward-Looking Statement

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking information and statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information contained herein may include, but is not limited to, information concerning the Offering and the use of any proceeds raised under the Offering.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements.

An investment in securities of the Company is speculative and subject to several risks including, without limitation, the risks discussed under the heading “Risk Factors” in the Company’s filing statement dated February 25, 2025. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information and forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended.

In connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice. 

SOURCE Boardwalktech Software Corp.

Continue Reading

Trending